Carl Zeiss Meditec AG
AFX.DE - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.41B
Close$
$25.83
26.1% downside
Current Fair Value
26.1% downsideOvervalued by 26.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.41 Billion |
|---|---|
| Enterprise Value | $3.41 Billion |
| Annual dividend | $0.55 |
| Dividend yield | 1.57% |
| Earnings per Share | $1.61 |
| Beta | 1.36 |
| Outstanding Shares | 86,302,842 |
Return
| Return on Equity | 5.54% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 20.93 |
|---|---|
| PEG | 22.28 |
| Price to Sales | 1.17 |
| Price to Book Ratio | 1.46 |
| Enterprise Value to Revenue | 1.28 |
| Enterprise Value to EBIT | 14.13 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.48
Consensus analyst estimateRevenue Estimate
$618.98 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 10, 2026
EPS Estimate
$0.48
Consensus analyst estimateRevenue Estimate
$618.98 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Carl Zeiss Meditec AG
5,784 employees
CEO: Andreas Pecher
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for ...